Spots Global Cancer Trial Database for Phase 3 Study to Treat Patients With Soft Tissue Sarcomas
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase 3 Study to Treat Patients With Soft Tissue Sarcomas
Official Title: A Multicenter, Randomized, Open-Label Phase 3 Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Investigator's Choice in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcomas Who Either Relapsed or Were Refractory to Prior Non-Adjuvant Chemotherapy
Study ID: NCT02049905
Study Description
Brief Summary: The purpose of this study is to determine the efficacy and safety of aldoxorubicin in subjects with metastatic, locally advanced, or unresectable soft tissue sarcomas.
Detailed Description:
Eligibility
Minimum Age: 15 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Alabama at Birmingham, Birmingham, Alabama, United States
Arizona Oncology Associates, PC, Phoenix, Arizona, United States
The University of Arizona, Tucson, Arizona, United States
City of Hope Medical Group, Duarte, California, United States
Samuel Oschin Cancer Center, Los Angeles, California, United States
UCLA Medical Center, Los Angeles, California, United States
Sarcoma Oncology Center, Santa Monica, California, United States
Stanford University Medical Center, Stanford, California, United States
U of CO Health Sciences Center, Aurora, Colorado, United States
Rocky Mountain Cancer Centers, Denver, Colorado, United States
Mayo Clinic, Jacksonville, Florida, United States
Moffitt Cancer Center, Tampa, Florida, United States
Georgia Cancer Specialists, Atlanta, Georgia, United States
Northwestern Medical Faculty Foundation, Chicago, Illinois, United States
Edward Cancer Center, Naperville, Illinois, United States
Oncology Specialists, SC, Niles, Illinois, United States
Kansas City Cancer Center, Overland Park, Kansas, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
University of Michigan, Ann Arbor, Michigan, United States
University of Minnesota, Minneapolis, Minnesota, United States
Mayo Clinic, Rochester, Minnesota, United States
Washington University, Saint Louis, Missouri, United States
Nebraska Methodist Hospital, Omaha, Nebraska, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
Levine Cancer Institute, Charlotte, North Carolina, United States
Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States
University Hospitals Case Medical Center, Cleveland, Ohio, United States
Cleveland Clinic, Cleveland, Ohio, United States
The James Cancer Hospital and Solove Research Institute, Columbus, Ohio, United States
Center for Health and Healing, Portland, Oregon, United States
Jefferson Medical College, Philadelphia, Pennsylvania, United States
U of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States
Vanderbilt University, Nashville, Tennessee, United States
Fletcher Allen Health Care, Burlington, Vermont, United States
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Royal North Shore Hospital, Saint Leonards, New South Wales, Australia
Westmead Hospital, Westmead, New South Wales, Australia
Cross Cancer Institute, Edmonton, Alberta, Canada
Juravinski Cancer Center, Hamilton, Ontario, Canada
McGill University, Montreal, Quebec, Canada
Instituto Clinico Oncologica del Sur (ICOS), Temuco, Araucanía, Chile
Herlev Hospital, Herlev, , Denmark
Institut Bergonie, Bordeaux Cedex, Aquitaine, France
Centre Georges Francois Leclerc, Dijon, Bourgogne, France
Centre Hospitalier Regional et Universitaire - Hospital Bretonneau, Tours, Centre-Val-de-Loire, France
Hopital Rene Huguenin - Institut Curie, Saint-Cloud, Ile-de-France, France
Institut Gustave Roussy, Villejuif, Ile-de-France, France
Centre Leon Berard, Lyon, Rhone-Alpes, France
Magyar Honvedseg Egeszsegugyi Kozpont, Budapest, , Hungary
Rambam Medical Center, Haifa, , Israel
Sharet Institute of Oncology Hadassah Ein Karem Medical Center, Jerusalem, , Israel
Chaim Sheba Medical Center, Ramat Gan, , Israel
Tel Aviv Sourasky Medical Center, Tel Aviv, , Israel
Fondazione del Piemonte per l'Oncologia, Candiolo, Torino, Italy
Azienda Ospedaliero-Universitaria di Bologna-Policlinico S Orsola-Malpighi, Bologna, , Italy
IRCCS Instituto Ortopedico Rizzoli, Bologna, , Italy
Istituto Europeo di Oncologia Milano, Milano, , Italy
Istituto Oncologico Veneto, Padova, , Italy
Leiden Universitair Medisch Centrum, Leiden, Zuid-Holland, Netherlands
Instytut im.Marii Sklodowskiej-Curie, Warszawa, , Poland
State Institution "Blokhin Cancer Research Centre RAMS", Moscow, , Russian Federation
City Oncology Hospital #2, Moscow, , Russian Federation
Republican Clinical Oncologic Dispensary of Ministry of Health Republic Tatarstan, Tatarstan, , Russian Federation
Hospital Universitario Son Espases, Palma de Mallorca, Baleares, Spain
Consorcio Hospitalario Provincial de Castellon, Castellón de la Plana, Castellon, Spain
Hospital Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain
Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain
Hospital Santa Creu i Sant Pau, Barcelona, , Spain
Inst Catala D'Oncologia, Barcelona, , Spain
Hospital Universitario La Paz, Madrid, , Spain
Centro Integral Oncologico Clara Campal, Hospital de Madrid Norte-San Chinarro, Madrid, , Spain
Hospital San Carlos Madrid, Madrid, , Spain
Hospital Universitario Miguel Servet, Zaragoza, , Spain
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
